And Then There Were Three: Time to Move Onward in COPD Drug Development Beyond LAMA/LABA/ICS at Last?

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

And then there were two

A second enzyme that removes acetyl groups from lysine residues in E. coli been discovered and represents the founding member of a new enzyme family.

متن کامل

Genome Sequencing: And Then There Were Six

The genome of the fission yeast Schizosaccharomyces pombe has been sequenced, bringing the number of sequenced eukaryotic genomes to six. Analysis of the sequence predicts only 4824 protein coding genes, the smallest number yet recorded for a free-living eukaryote.

متن کامل

'And then there were three': highly efficient uptake of potassium by foliar trichomes of epiphytic bromeliads.

BACKGROUND AND AIMS Vascular epiphytes have to acquire nutrients from atmospheric wash out, stem-flow, canopy soils and trapped litter. Physiological studies on the adaptations to nutrient acquisition and plant utilization of nutrients have focused on phosphorus and nitrogen; potassium, as a third highly abundant nutrient element, has received minor attention. In the present study, potassium up...

متن کامل

Is it time to move beyond the "O" in early COPD?

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally [1] and is the focus of primary and tertiary prevention programmes [2, 3]. Primary prevention has focused on reduction of risk factors, such as tobacco smoke exposure [4] whereas tertiary prevention has focused on reducing exacerbations or improving symptoms among patients with established disease [5]. Mis...

متن کامل

CKD classification: time to move beyond KDOQI.

The number of patients with ESRD is increasing worldwide. Despite recent advances in our understanding of the uremic state and improvements in the science and technology of renal replacement therapy, the morbidity and mortality of these patients is unacceptably high: More than 20% per year. Moreover, the health care cost of treating ESRD exceeds $17 billion annually in the United States alone.1...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Pulmonary Therapy

سال: 2018

ISSN: 2364-1754,2364-1746

DOI: 10.1007/s41030-018-0059-5